Chao‐Chuan Wu

528 total citations
23 papers, 400 citations indexed

About

Chao‐Chuan Wu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Chao‐Chuan Wu has authored 23 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Chao‐Chuan Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Gallbladder and Bile Duct Disorders (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Chao‐Chuan Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Gallbladder and Bile Duct Disorders (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Chao‐Chuan Wu collaborates with scholars based in Taiwan, United States and Czechia. Chao‐Chuan Wu's co-authors include I‐Rue Lai, Po‐Li Wei, Nien‐Tsung Lin, Yao-Jen Chang, Chi‐Tan Hu, Robert J. Chen, Ming‐Te Huang, Wen‐Jeng Lee, Pei‐Yu Chiou and Wei‐Jei Lee and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and BMC Public Health.

In The Last Decade

Chao‐Chuan Wu

22 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao‐Chuan Wu Taiwan 10 191 92 58 47 44 23 400
Laura Farr United States 8 130 0.7× 78 0.8× 14 0.2× 41 0.9× 24 0.5× 10 470
Pien Hellebrekers Netherlands 9 67 0.4× 83 0.9× 10 0.2× 17 0.4× 22 0.5× 11 407
Momodou L. Jammeh United States 7 56 0.3× 96 1.0× 61 1.1× 106 2.3× 255 5.8× 15 627
Maher Osman Denmark 10 297 1.6× 28 0.3× 15 0.3× 61 1.3× 129 2.9× 21 399
David H Felix United Kingdom 11 36 0.2× 130 1.4× 10 0.2× 25 0.5× 38 0.9× 29 434
J. M. Wolfe United States 11 108 0.6× 37 0.4× 29 0.5× 45 1.0× 22 0.5× 22 439
Kristina Svennerholm Sweden 9 35 0.2× 209 2.3× 23 0.4× 58 1.2× 16 0.4× 20 375
Junxian Zhang China 13 97 0.5× 188 2.0× 10 0.2× 16 0.3× 22 0.5× 41 533
Niga Nawroly United Kingdom 6 70 0.4× 59 0.6× 3 0.1× 43 0.9× 60 1.4× 8 463
Cristopher Soto Chile 7 139 0.7× 103 1.1× 7 0.1× 38 0.8× 26 0.6× 11 406

Countries citing papers authored by Chao‐Chuan Wu

Since Specialization
Citations

This map shows the geographic impact of Chao‐Chuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Chuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Chuan Wu more than expected).

Fields of papers citing papers by Chao‐Chuan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Chuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Chuan Wu. The network helps show where Chao‐Chuan Wu may publish in the future.

Co-authorship network of co-authors of Chao‐Chuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Chuan Wu. A scholar is included among the top collaborators of Chao‐Chuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Chuan Wu. Chao‐Chuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Peng, Tzu‐Rong, et al.. (2022). Therapeutic efficacy of nivolumab plus sorafenib therapy in patients with unresectable hepatocellular carcinoma. International Immunopharmacology. 112. 109223–109223. 8 indexed citations
4.
Cheng, Yu‐Ming, et al.. (2021). Predictors of recurrence in early hepatocellular carcinoma patients treated with surgical resection. Advances in digestive medicine. 10(1). 21–27. 2 indexed citations
5.
Tseng, Hui‐Hwa, Nan–Hua Chou, Yen-Chih Chen, et al.. (2021). Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis. Molecular Therapy — Oncolytics. 22. 180–194. 24 indexed citations
6.
Peng, Tzu‐Rong, et al.. (2021). Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma. Tzu Chi Medical Journal. 34(2). 219–225. 3 indexed citations
7.
Chen, Yen‐Chih, et al.. (2020). Involvement of the MicroRNA-1-LITAF Axis in Gastric Cancer Cell Growth and Invasion. Anticancer Research. 40(11). 6247–6256. 7 indexed citations
8.
Wu, Chao‐Chuan, Chih‐Wei Tseng, Kuo‐Chih Tseng, et al.. (2020). Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan. Journal of the Formosan Medical Association. 120(5). 1249–1258. 8 indexed citations
9.
Chang, Yao-Jen, et al.. (2017). Is vegetarian diet associated with a lower risk of breast cancer in Taiwanese women?. BMC Public Health. 17(1). 800–800. 45 indexed citations
11.
Wu, Chao‐Chuan, et al.. (2015). Unusual presentation of a low-grade intraductal papillary neoplasm of the bile duct. Formosan Journal of Surgery. 48(2). 68–71. 1 indexed citations
12.
Wu, Jia‐Ru, Chi‐Tan Hu, Ren-In You, et al.. (2015). Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression. Oncotarget. 6(32). 32526–32544. 23 indexed citations
13.
Hu, Chi‐Tan, Pei‐Yu Chiou, Chao‐Chuan Wu, et al.. (2009). Analysis of Resistance to Clarithromycin and Virulence Markers in Helicobacter pylori Clinical Isolates from Eastern Taiwan. Tzu Chi Medical Journal. 21(2). 123–128. 4 indexed citations
14.
Wu, Chao‐Chuan, et al.. (2007). Torsion of the gallbladder. Surgery. 143(2). 294–295. 2 indexed citations
15.
Hu, Chi‐Tan, et al.. (2006). Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. Journal of Gastroenterology and Hepatology. 22(5). 720–723. 45 indexed citations
16.
Wu, Chao‐Chuan, et al.. (2005). Clinical Relevance of the vacA , iceA , cagA , and flaA Genes of Helicobacter pylori Strains Isolated in Eastern Taiwan. Journal of Clinical Microbiology. 43(6). 2913–2915. 17 indexed citations
17.
Huang, Ming‐Te, Po‐Li Wei, Chao‐Chuan Wu, et al.. (2001). . Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 11(5). 306–312. 2 indexed citations
18.
Huang, Ming‐Te, Po‐Li Wei, Chao‐Chuan Wu, et al.. (2001). Needlescopic, Laparoscopic, and Open Appendectomy: A Comparative Study. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 11(5). 306–312. 59 indexed citations
19.
Lee, Wei‐Jei, et al.. (2001). Laparoscopic Versus Open Vertical Banded Gastroplasty for the Treatment of Morbid Obesity. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 11(1). 9–13. 17 indexed citations
20.
Lee, Wei‐Jei, et al.. (2001). Laparoscopic versus open vertical banded gastroplasty for the treatment of morbid obesity.. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 11(1). 9–13. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026